Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/12/2013 → 31/07/2018 |
Collaborative partners
- King's College London (lead)
- Argenta Discovery 2009 Ltd
- Millipore UK Ltd
- Numedicus Ltd
Funding
- Wellcome Trust: £3,394,560.00
Discovery and development of novel small molecule inhibitors of the human Hyperpolarization-activated Cyclic Nucleotide-gated 2 (HCN2) ion channel for the treatment of inflammatory and neuropathic pain
- McNaughton, Peter (Primary Investigator)
Project: Research